Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-19-045148
Filing Date
2019-08-08
Accepted
2019-08-08 17:06:38
Documents
2
Period of Report
2019-08-06

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 4146
2 POA DOCUMENT poa.txt EX-24.3_867946 4016
  Complete submission text file 0001209191-19-045148.txt   9801
Mailing Address 3200 SOUTHWEST FREEWAY SUITE 2240 HOUSTON TX 77027
Business Address 3200 SOUTHWEST FREEWAY SUITE 2240 HOUSTON TX 77027 (713) 400-6400
Marker Therapeutics, Inc. (Issuer) CIK: 0001094038 (see all company filings)

EIN.: 880277072 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 888 SEVENTH AVE 29TH FL NEW YORK NY 10106
Business Address
ELMS STEVE (Reporting) CIK: 0001250195 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37939 | Film No.: 191010484